HRSA Approves Manufacturer 340B Rebate Model Applications

Upcoming Events

Hospital Board Leaders' Program (third out of series of three programs)- Nov. 18

This program is for board chairs, chair-elects , vice chairs and board members in line to be chair. Session resources will be shared with the board members CEOadministrator since they will not be able to attend the program.

Noon Briefing: Navigating Immigration Visas in Health Care – Nov. 19

This Noon Briefing will provide an overview designed to help hospital leaders understand the fundamentals of immigration visas in health care settings. The session will address key visa types, common employer pitfalls, and steps to take before engaging in recruitment or sponsorship. Participants will gain a practical understanding of what questions to ask, when to seek legal guidance and how to prepare their organization to navigate these requirements with confidence.

Rural Health Symposium - Nov. 20

This symposium aims to provide attendees with the skills, ideas and information necessary to survive in the rapidly changing world of rural health care. It is designed for senior-level administrators, hospital trustees and others interested in rural health issues.

KHA Legislative Dinner - Nov. 20

We are excited to offer the membership the opportunity to discuss some of the challenges and opportunities at your hospitals with policymakers. This year, we are excited to host legislative dinners throughout the state featuring interactive conversations about hospital challenges.

Pioneer Health Network Board Meeting - Dec. 3

For more information about this event, contact Dee Dee Dewell at (316) 755-5633.

Current Report Articles

‹‹ Back To List

HRSA Approves Manufacturer 340B Rebate Model Applications

340B2 (Nov. 14, 2025) – The Health Resources and Services Administration Office of Pharmacy Affairs has approved eight manufacturer applications for participation in the 340B Rebate Model Pilot Program, which is set to start on Jan. 1, 2026. The drugs included in the rebate model plans are Eliquis, Enbrel, Farxiga, Imbruvica, Januvia, Jardiance, Novolog (various), Stelara and Xarelto. All approved applications indicate they will use the Beacon IT platform. Details about all drugs and manufacturers approved for the rebate model, along with more information such as FAQs, can be found on the HRSA 340B Rebate Model Pilot Program webpage.

In our comment letter to HRSA on Aug. 28, 2025, the Kansas Hospital Association expressed strong opposition to the 340B Rebate Model Pilot. We will continue to fight for 340B protections for Kansas hospitals, as well as the patients and communities they serve.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News